Sales growth across all segments and regions
Q1'23 saw reported revenues of USD 181m (0% vs. company-collected consensus), corresponding to reported growth of 7% across the group. Growth was recorded in all segments and regions, but primarily driven by APAC, which was up 12% (but it only accounts for ~9% of group sales) and Americas up 12% (~48% of group sales). On the segment side, prosthetics was up 12%, with sales of USD 91m (beating cons by 2%). The growth was also helped by price increases, with the company mentioning that most of the reimbursement systems it works with have increased prices from zero percent to inflation-related price increases.
Aktuellt
SENASTE
